MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$2.70 USD
-0.05 (-1.82%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $2.72 +0.02 (0.74%) 6:38 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, MDxHealth SA has a market cap of $130.04M, which represents its share price of $2.75 multiplied by its outstanding shares number of 47.29M. As a small-cap company, MDXH's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MDXH 2.70 -0.05(-1.82%)
Will MDXH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MDXH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDXH
MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates
MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates
MDXH: What are Zacks experts saying now?
Zacks Private Portfolio Services
10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH)
Other News for MDXH
MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Preliminary Q2 2025 MDxHealth SA Earnings Call Transcript
Mdxhealth (MDXH) to Acquire Exosome Diagnostics Business from Bio-Techne
Bio-Techne to divest Exosome Diagnostics business to Mdxhealth
MDxHealth reports Q2 EPS (15c) vs. (42c) last year